Identification of the potential risk factors for monoclonal gammopathy of undetermined significance of progression.

about

Identification of the potential risk factors for monoclonal gammopathy of undetermined significance of progression.

Item

http://www.wikidata.org/entity/Q38199534

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Identification of the potentia ...... d significance of progression.

@en

type

Item

label

Identification of the potentia ...... d significance of progression.

@en

prefLabel

Identification of the potentia ...... d significance of progression.

@en

P1476

Identification of the potentia ...... d significance of progression.

@en

P2093

Jian Hou

http://www.w3.org/2001/XMLSchema#string

Juan Du

http://www.w3.org/2001/XMLSchema#string

Rong Li

http://www.w3.org/2001/XMLSchema#string

P2860

EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine

Massive genomic rearrangement acquired in a single catastrophic event during cancer development

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.

Prevalence and type of monoclonal gammopathy of undetermined significance in an apparently healthy Nigerian population: a cross sectional study.

Prevalence of monoclonal gammopathy of undetermined significance.

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.

P304

11-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/1607845414Y.0000000163

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24670051

http://www.w3.org/2001/XMLSchema#string